Skip to main content

AN2 Therapeutics, Inc. (NASDAQ: ANTX) Investor Investigation Concerning Potential Securities Laws Violations Announced

  • Investors who purchased shares of AN2 Therapeutics, Inc. (NASDAQ: ANTX), have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

An investigation on behalf of investors of AN2 Therapeutics, Inc. (NASDAQ: ANTX) shares over potential securities laws violations by AN2 Therapeutics, Inc. and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of AN2 Therapeutics, Inc....

You must register (for free) or login to view the entire investigation.